Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 5639 Results
March 20, 2025
QXO to Acquire Beacon Roofing Supply for $11 Billion
$11 Billion
March 19, 2025
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
$330 Million
March 18, 2025
Lazard acted as Sole Financial Advisor to Ipsen on its inaugural €500m bond issuance, €1,500m RCF renewal, and inaugural Investment Grade public rating achievement
$2.1 Billion
March 17, 2025
Claranet Group sold its Portuguese subsidiary to NOS SGPS
$159.5 Million
March 14, 2025
The Belgian government signs an agreement with ENGIE on the extension of Tihange 3 and Doel 4 nuclear reactors and all obligations related to nuclear waste
$25.1 Billion
March 14, 2025
Open Fiber has raised additional €1.05 billion credit lines and additional c.€1 billion shareholders’ commitment - on top of the €7.2 billion from the previous project financing facility – to secure its long term funding and complete its c.€10 billion investment plan
$11.5 Billion
March 13, 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
$6.7 Billion
March 12, 2025
Lazard acted as Sole Financial Advisor to Viridien’s successful pricing of its $450m and €475m Senior Secured Notes offering, signing of its $125m super senior RCF and upgrade of its Senior Secured Notes ratings with S&P, Moody’s and Fitch
$1 Billion
March 11, 2025
SSI Diagnostica Group Announces a Successful Refinancing with Bridgepoint Credit, Nordea and Nykredit
Undisclosed
March 11, 2025